Infectious Diseases 1403 - Infectious Disease Alert - Mar 01, 2010

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editors
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Frank Bia, MD, MPH
Professor (Emeritus) of Internal Medicine (Infectious Disease and Clinical Microbiology)
Yale University School of Medicine

Board Member and Peer Reviewers
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Sciences Center

Mary-Louise Scully, MD
Director, Travel and Tropical Medicine Center
Sansum Clinic
Santa Barbara, CA

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Joseph F. John, MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Ellen Jo Baron, MD, PhD
Professor of Pathology and Medicine
Stanford University
Clinical Microbiology and Virology Laboratories
Stanford University Medical Center


  • The Expanding Syndrome of Necrotizing Fasciitis
  • Pneumocystis Colonization and Pulmonary Infection in Immunocompetent Adults
  • Acyclovir for Prevention of HIV Transmission
  • Building Laboratory Capacity in Resource-poor Settings: Part 1
  • Land-to-sea Transmission of Toxoplasmosis ... And Back Again
  • Updates


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau for Merck, Pfizer, Wyeth, Ortho-McNeil (J&J), Schering-Plough, and Cubist, does research for the National Institute of Health, and is an advisory board member for Schering-Plough, Ortho-McNeil (J&J), and Cepheid. Editor, Frank Bia, MD, MPH, Peer Reviewers Timothy Jenkens, MD, Mary-Louise Scully, MD, and Associate Editor Ellen Jo Baron, MD, PhD, report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study. Updates Author Carol A. Kemper, MD, FACP, does research for GSK Pharmaceuticals, Abbott Laboratories, and Merck. Associate Editor Joseph F. John, MD, FACP, FIDSA, FSHEA is a consultant for Cubist, Genzyme, and bioMerieux, and is on the speaker's bureau for Cubist, GSK, Merck, Bayer, and Wyeth. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for GSK and Cubist.

Copyright 2010 AHC Media. All rights reserved.